Copyright
©The Author(s) 2018.
World J Orthop. Sep 18, 2018; 9(9): 120-129
Published online Sep 18, 2018. doi: 10.5312/wjo.v9.i9.120
Published online Sep 18, 2018. doi: 10.5312/wjo.v9.i9.120
Figure 2 Osteonecrosis of the femoral head treated with a single injection of 500 μg vascular endothelial growth factor (t-VEGFμ group); specimen retrieved 12 wk postoperatively.
A well-formed cancellous bone network with thickened lamellar trabeculae is visible, while the in between spaces are filled with normal marrow cells (M). A: Newly formed (vT) were noticed on the surface of the trabeculae (T) (Obj. × 10, H and E). B: Almost all trabeculae’s (T) surface is covered by newly (vT) formed bone (Obj. × 10, TB).
- Citation: Dailiana ZH, Stefanou N, Khaldi L, Dimakopoulos G, Bowers JR, Fink C, Urbaniak JR. Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines. World J Orthop 2018; 9(9): 120-129
- URL: https://www.wjgnet.com/2218-5836/full/v9/i9/120.htm
- DOI: https://dx.doi.org/10.5312/wjo.v9.i9.120